Company Filing History:
Years Active: 2025
Title: Innovations of Inventor Kai Lau
Introduction
Kai Lau is an accomplished inventor based in New South Wales, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions. His innovative work has led to the creation of a patent that addresses important aspects of drug formulation and preservation.
Latest Patents
Kai Lau holds a patent for "Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative." This patent discloses compositions that include one or more water-soluble complexes, each comprising a cyclodextrin or a cyclodextrin derivative and a hydrophobic drug. The compositions also contain at least one preservative and at least one co-solvent. Notably, these compositions are effectively preserved according to the European Pharmacopoeia 2011 Test for Efficacy of Antimicrobial Preservation, meeting at least the B criteria for parenterals. Additionally, they satisfy the criteria for Category 1 (injectable) products as outlined in the United States Pharmacopeia 2011 Guidelines for Antimicrobial Effectiveness Testing. This patent represents a significant advancement in the field of injectable pharmaceuticals.
Career Highlights
Kai Lau is currently associated with Zoetis Services LLC, a company known for its commitment to animal health and innovative pharmaceutical solutions. His work at Zoetis has allowed him to focus on developing effective and safe pharmaceutical compositions that can enhance treatment options in veterinary medicine.
Collaborations
Throughout his career, Kai Lau has collaborated with talented professionals, including Kirby Shawn Pasloske and Sarah Jane Richardson. These collaborations have contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
In summary, Kai Lau is a notable inventor whose work in injectable pharmaceutical compositions has made a significant impact in the field. His patent reflects a commitment to advancing pharmaceutical formulations that ensure safety and efficacy.